These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8916562)

  • 1. Prescribing practices for the management of headache in Newfoundland and Labrador.
    Furlong S; Pryse-Phillips W; Crowley M; Turner CJ
    Headache; 1996 Oct; 36(9):542-6. PubMed ID: 8916562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of ergotamine and sumatriptan use in the Netherlands from 1991 to 1997.
    Rahimtoola H; Egberts AC; Buurma H; Tijssen CC; Leufkens HG
    Cephalalgia; 2001 Jun; 21(5):596-603. PubMed ID: 11472386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
    Gaist D
    Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medication-overuse headache].
    Rabe K; Katsarava Z
    MMW Fortschr Med; 2006 Aug; 148(35-36):37-8. PubMed ID: 16995362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is overuse of sumatriptan a problem? A population-based study.
    Gaist D; Hallas J; Sindrup SH; Gram LF
    Eur J Clin Pharmacol; 1996; 50(3):161-5. PubMed ID: 8737753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data.
    Gaist D; Andersen M; Aarup AL; Hallas J; Gram LF
    Br J Clin Pharmacol; 1997 Apr; 43(4):429-33. PubMed ID: 9146856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
    Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N
    J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable].
    Perearnau P; Vuillemet F; Schick J; Weill G
    Rev Neurol (Paris); 2006 Mar; 162(3):347-57. PubMed ID: 16585890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of autogenic training on drug consumption in patients with primary headache: an 8-month follow-up study.
    Zsombok T; Juhasz G; Budavari A; Vitrai J; Bagdy G
    Headache; 2003 Mar; 43(3):251-7. PubMed ID: 12603644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disparity in access to new medication by type of health insurance: lessons from Germany.
    Krobot KJ; Miller WC; Kaufman JS; Christensen DB; Preisser JS; Ibrahim MA
    Med Care; 2004 May; 42(5):487-91. PubMed ID: 15083110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
    Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
    Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and treatment of migraine.
    Skaer TL
    Clin Ther; 1996; 18(2):229-45; discussion 228. PubMed ID: 8733984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problems of migraine headache treatment].
    Vilionskis A; Vaitkus A
    Medicina (Kaunas); 2002; 38(7):679-84. PubMed ID: 12474651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptans versus analgesics.
    Robbins L
    Headache; 2002 Oct; 42(9):903-7. PubMed ID: 12390618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing practices of migraine-specific pharmacotherapy associated with emergency department use for migraine.
    Cheng V; Billups SJ; Saseen JJ
    Headache; 2021 Mar; 61(3):455-461. PubMed ID: 33377525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.
    Cady RK; Gutterman D; Saiers JA; Beach ME
    Cephalalgia; 1997 Aug; 17(5):588-90. PubMed ID: 9251874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The latest in headache treatment].
    Calero Muñoz S; Fariñas Balaguer O; Nieto Márquez L; Cobo Guerrero S
    Aten Primaria; 2002 May; 29(9):565-8. PubMed ID: 12061989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.